REN-001
/ Rocket Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 14, 2023
"$RPHM Reneo Pharmaceuticals Achieves Target Enrollment in the Pivotal STRIDE Study of Mavodelpar (REN001) in Primary Mitochondrial Myopathies https://t.co/Fh8cDHJoBS"
(@stock_titan)
Myositis
1 to 1
Of
1
Go to page
1